Gastroenterology
Volume 137, Issue 3 , Pages 997-1005.e4 , September 2009

Glucagon-Like Peptide-2 Increases Intestinal Lipid Absorption and Chylomicron Production via CD36

  • Joanne Hsieh

      Affiliations

    • Molecular Structure and Function, Hospital for Sick Children, Toronto, Ontario, Canada
    • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Christine Longuet

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Adriano Maida

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Jasmine Bahrami

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Elaine Xu

      Affiliations

    • Molecular Structure and Function, Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Christopher L. Baker

      Affiliations

    • Molecular Structure and Function, Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Patricia L. Brubaker

      Affiliations

    • Department of Physiology, University of Toronto, Toronto, Ontario, Canada
    • Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Daniel J. Drucker

      Affiliations

    • Department of Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Khosrow Adeli

      Affiliations

    • Molecular Structure and Function, Hospital for Sick Children, Toronto, Ontario, Canada
    • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests Address requests for reprints to: Khosrow Adeli, MD, Division of Clinical Biochemistry, DPLM, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Atrium Room 3652, Toronto, Ontario, Canada, M5G 1X8. fax: (416) 813-6257

Received 17 September 2008 ,Accepted 20 May 2009.

References 

  1. Boquist S, Ruotolo G, Tang R, et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation. 1999;100:723–728
  2. Nakano T, Nakajima K, Niimi M, et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clin Chim Acta. 2008;390:38–43
  3. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733–749
  4. Gylling H, Tuominen JA, Koivisto VA, et al. Cholesterol metabolism in type 1 diabetes. Diabetes. 2004;53:2217–2222
  5. Hussain MM. A proposed model for the assembly of chylomicrons. Atherosclerosis. 2000;148:1–15
  6. Guo Q, Avramoglu RK, Adeli K. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metabolism. 2005;54:689–697
  7. Federico LM, Naples M, Taylor D, et al. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes. 2006;55:1316–1326
  8. Haidari M, Leung N, Mahbub F, et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance (Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction). J Biol Chem. 2002;277:31646–31655
  9. Zoltowska M, Ziv E, Delvin E, et al. Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes. 2003;52:2539–2545
  10. Estall JL, Drucker DJ. Glucagon-like peptide-2. Annu Rev Nutr. 2006;26:391–411
  11. Yusta B, Huang L, Munroe D, et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology. 2000;119:744–755
  12. Guan X, Karpen HE, Stephens J, et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology. 2006;130:150–164
  13. Orskov C, Hartmann B, Poulsen SS, et al. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept. 2005;124:105–112
  14. Tang-Christensen M, Larsen PJ, Thulesen J, et al. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med. 2000;6:802–807
  15. Koehler JA, Yusta B, Drucker DJ. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways. Mol Endocrinol. 2005;19:459–473
  16. Dube PE, Forse CL, Bahrami J, et al. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology. 2006;131:589–605
  17. Cheeseman CI. Up-regulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol. 1997;273:R1965–R1971
  18. Au A, Gupta A, Schembri P, et al. Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2. Biochem J. 2002;367:247–254
  19. Rocca AS, LaGreca J, Kalitsky J, et al. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology. 2001;142:1148–1155
  20. Meier JJ, Nauck MA, Pott A, et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology. 2006;130:44–54
  21. Qin B, Qiu W, Avramoglu RK, et al. Tumor necrosis factor-α induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes. 2007;56:450–461
  22. Nassir F, Wilson B, Han X, et al. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem. 2007;282:19493–19501
  23. Brubaker PL, Izzo A, Hill M, et al. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol. 1997;272:E1050–E1058
  24. Pedersen NB, Hjollund KR, Johnsen AH, et al. Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects. Regul Pept. 2008;146:310–320
  25. Stahl A, Hirsch DJ, Gimeno RE, et al. Identification of the major intestinal fatty acid transport protein. Mol Cell. 1999;4:299–308
  26. Milger K, Herrmann T, Becker C, et al. Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci. 2006;119:4678–4688
  27. Drover VA, Ajmal M, Nassir F, et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest. 2005;115:1290–1297
  28. Nauli AM, Nassir F, Zheng S, et al. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology. 2006;131:1197–1207
  29. Eyre NS, Cleland LG, Tandon NN, et al. Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J Lipid Res. 2007;48:528–542
  30. Luiken JJ, Koonen DP, Willems J, et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes. 2002;51:3113–3119
  31. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999;274:19055–19062
  32. Goudriaan JR, den Boer MA, Rensen PC, et al. CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance. J Lipid Res. 2005;46:2175–2181
  33. Densupsoontorn N, Carpentier YA, Racine R, et al. CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro. J Nutr. 2008;138:257–261
  34. Pohl J, Ring A, Korkmaz U, et al. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell. 2005;16:24–31
  35. Levy E, Stan S, Delvin E, et al. Localization of microsomal triglyceride transfer protein in the Golgi: possible role in the assembly of chylomicrons. J Biol Chem. 2002;277:16470–16477
  36. Amato A, Baldassano S, Serio R, et al. Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. Am J Physiol Gastrointest Liver Physiol. 2009;296:G678–G684
  37. Bozkurt A, Naslund E, Holst JJ, et al. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. Regul Pept. 2002;107:129–135
  38. Fischer KD, Dhanvantari S, Drucker DJ, et al. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am J Physiol. 1997;273:E815–E820
  39. Gleeson A, Anderton K, Owens D, et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia. 1999;42:944–948

 Conflicts of interest The authors disclose the following: Daniel J. Drucker (Dr Drucker is a party to a licensing agreement among the University of Toronto, the University Health Network, and NPS Pharmaceuticals Inc in regard to the clinical development of GLP-2). The remaining authors disclose no conflicts.

 Funding Supported by CIHR grant MOP-53093 (to K.A.) and CIHR grant MOP-14799 (to D.J.D.). J.H. is supported by the NSERC CGS M, Restracomp, and CIHR CGS D fellowships.

PII: S0016-5085(09)00868-3

doi: 10.1053/j.gastro.2009.05.051

Gastroenterology
Volume 137, Issue 3 , Pages 997-1005.e4 , September 2009

Article Tools

* Image Usage & Resolution